Author:
Phrathep Davong D,Anthony Stefan,Healey Kevin D,Khan Hamaad,Herman Michael
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Idiopathic portal hypertension and its pathology;Okudaira M;Semin Liver Dis,2002
2. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study;Kovari H;Clin Infect Dis,2009
3. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV;Schiano TD;Virchows Arch,2011
4. FDA Drug Safety Communication. Serious liver disorder associated with the use of Videx/Videx EC (didanosine). (2017). Accessed: January 1, 2023: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-ser....
5. AIDS and thrombosis: retrospective study of 131 HIV-infected patients;Saif MW;AIDS Patient Care STDS,2001